MedTrace Logo

Wearable Devices and Biomarkers Project (Healthiomics)

NCT05106725 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3500

Last updated 2024-08-21

No results posted yet for this study

Summary

The purpose of this study is to collect clinical data, biological specimens (e.g., blood, tumor, cerebrospinal fluid, urine sample, etc.), and digital health data from patients with tumors, cancer and/or neurological disorders in order to perform research studies that could advance patient care. By collecting these specimens, the investigators plan to create and maintain a biorepository to make data and specimens available to collaborating investigators performing research to discover predictive biomarkers, patterns of care, and personalized treatments that could directly improve the care of our patients through focused proof-of-concept clinical trials.

Conditions

Sponsors & Collaborators

  • CureScience

    lead OTHER

Principal Investigators

  • Feng Lin, MD PhD · CureScience

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05106725 on ClinicalTrials.gov